Advert - Jazz Pharmaceuticals UK – Case AUTH/3918/6/24

• Date posted
  11 July 2025
• Sanction
  Advertisement,
• Case number/s
  AUTH/3918/6/24 - Complainant v Jazz Pharmaceuticals

For failing to provide important information about hepatic impairment relating to the use of
Epidyolex (cannabidiol) within a video presentation, Jazz Pharmaceuticals UK was ruled in
breach of the following clauses of the 2021 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the
pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 6.1 - For providing misleading information